{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:40:23Z","timestamp":1793497223981,"version":"4.5.0"},"reference-count":46,"publisher":"Centers for Disease Control MMWR Office","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Recomm. Rep."],"DOI":"10.15585\/mmwr.rr6906a1","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T14:58:30Z","timestamp":1595516310000},"page":"1-8","source":"Crossref","is-referenced-by-count":48,"title":["Testing and Clinical Management of Health Care Personnel Potentially Exposed to Hepatitis C Virus \u2014 CDC Guidance, United States, 2020"],"prefix":"10.15585","volume":"69","author":[{"given":"Anne C.","family":"Moorman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie A.","family":"de Perio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Goldschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kuhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Naggie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleem","family":"Kamili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip R.","family":"Spradling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart C.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark B.","family":"Russi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyasu H.","family":"Teshale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2020,7,24]]},"reference":[{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R1","article-title":"Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis.","volume":"50","author":"CDC","year":"2001","journal-title":"MMWR Recommend Rep"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jhin.2017.02.021","article-title":"Comparing non-safety with safety device sharps injury incidence data from two different occupational surveillance systems.","volume":"96","author":"Mitchell","year":"2017","journal-title":"J Hosp Infect"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R3","unstructured":"International Safety Center. EPINet sharps injury and blood and body fluid data reports. Charlottesville, VA: University of Virginia [undated]. https:\/\/internationalsafetycenter.org\/exposure-reports"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R4","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.ajic.2017.03.011","article-title":"Seroconversion rates among health care workers exposed to hepatitis C virus-contaminated body fluids: the University of Pittsburgh 13-year experience.","volume":"45","author":"Egro","year":"2017","journal-title":"Am J Infect Control"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4103\/0974-2727.187917","article-title":"Occurrence of needlestick and injuries among health-care workers of a tertiary care teaching hospital in North India.","volume":"9","author":"Goel","year":"2017","journal-title":"J Lab Physicians"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R6","first-page":"1469","article-title":"Occupational transmission of hepatitis C virus.","volume":"288","author":"Jagger","year":"2002","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R7","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1097\/MEG.0b013e3283470241","article-title":"Favorable outcome of acute occupational hepatitis C in healthcare workers: a multicenter French study on 23 cases.","volume":"23","author":"Morin","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R8","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1086\/497131","article-title":"Risk factors for hepatitis C virus transmission to health care workers after occupational exposure: a European case-control study.","volume":"41","author":"Yazdanpanah","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R9","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1086\/651579","article-title":"Challenge pools of hepatitis C virus genotypes 1-6 prototype strains: replication fitness and pathogenicity in chimpanzees and human liver-chimeric mouse models.","volume":"201","author":"Bukh","year":"2010","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R10","unstructured":"American Association for the Study of Liver Diseases; Infectious Diseases Society of America. HCV guidance: recommendations for testing, managing, and treating hepatitis C. Alexandria, VA; Arlington, VA: American Association for the Study of Liver Disease; Infectious Diseases Society of America [undated]. https:\/\/www.hcvguidelines.org"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R11","unstructured":"CDC. Reported number of acute hepatitis C cases\u2014United States, 2001\u20132017. In: Surveillance for viral hepatitis\u2014United States, 2017. Atlanta, GA: US Department of Health and Human Services, CDC; 2019. https:\/\/www.cdc.gov\/hepatitis\/statistics\/2017surveillance\/TablesFigures-HepC.htm"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","article-title":"Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies.","volume":"13","author":"Micallef","year":"2006","journal-title":"J Viral Hepat"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R13","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.cgh.2019.04.035","article-title":"Prevalence of spontaneous clearance of hepatitis C virus infection doubled from 1998 to 2017.","volume":"18","author":"Seo","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1086\/650298","article-title":"SHEA guideline for management of healthcare workers who are infected with hepatitis B virus, hepatitis C virus, and\/or human immunodeficiency virus.","volume":"31","author":"Henderson","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R15","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/cid\/ciy913","article-title":"Ledipasvir\/sofosbuvir for 8 weeks to treat acute hepatitis C virus infections in men with human immunodeficiency virus infections: sofosbuvir-containing regimens without interferon for treatment of acute HCV in HIV-1 infected individuals.","volume":"69","author":"Naggie","year":"2019","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S2468-1253(18)30414-X","article-title":"Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): an open-label, multicentre, single-arm, phase 3b trial.","volume":"4","author":"Boerekamps","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S1473-3099(16)30408-X","article-title":"Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 study.","volume":"17","author":"Deterding","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R18","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S2468-1253(17)30003-1","article-title":"Ledipasvir-sofosbuvir for 6 weeks to treat acute hepatitis C virus genotype 1 or 4 infection in patients with HIV coinfection: an open-label, single-arm trial.","volume":"2","author":"Rockstroh","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R19","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1111\/j.1537-2995.2009.02322.x","article-title":"Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion.","volume":"49","author":"Kleinman","year":"2009","journal-title":"Transfusion"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R20","unstructured":"Association of Public Health Laboratories. Interpretation of hepatitis C virus test results: guidance for laboratories. Silver Spring, MD: Association of Public Health Laboratories; 2019. https:\/\/www.aphl.org\/aboutAPHL\/publications\/Documents\/ID-2019Jan-HCV-Test-Result-Interpretation-Guide.pdf"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1046\/j.1537-2995.2000.40020143.x","article-title":"Committee report. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: report of the Interorganizational Task Force on Nucleic Acid Amplification Testing of Blood Donors.","volume":"40","author":"Busch","year":"2000","journal-title":"Transfusion"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R22","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1111\/j.1537-2995.2005.04390.x","article-title":"Dynamics of viremia in early hepatitis C virus infection.","volume":"45","author":"Glynn","year":"2005","journal-title":"Transfusion"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R23","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1002\/jmv.24010","article-title":"Dynamics of HCV RNA levels during acute hepatitis C virus infection.","volume":"86","author":"Hajarizadeh","year":"2014","journal-title":"J Med Virol"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R24","doi-asserted-by":"publisher","first-page":"6023","DOI":"10.1128\/JVI.79.10.6023-6034.2005","article-title":"Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection.","volume":"79","author":"Lavillette","year":"2005","journal-title":"J Virol"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R25","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1365-2893.2007.00900.x","article-title":"The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral therapy.","volume":"15","author":"Mosley","year":"2008","journal-title":"J Viral Hepat"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R26","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1046\/j.1537-2995.2002.00166.x","article-title":"Sensitivity of HCV core antigen and HCV RNA detection in the early infection phase.","volume":"42","author":"N\u00fcbling","year":"2002","journal-title":"Transfusion"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/cid\/cis921","article-title":"Frequent longitudinal sampling of hepatitis C virus infection in injection drug users reveals intermittently detectable viremia and reinfection.","volume":"56","author":"Page","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R28","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1084\/jem.194.10.1395","article-title":"Determinants of viral clearance and persistence during acute hepatitis C virus infection.","volume":"194","author":"Thimme","year":"2001","journal-title":"J Exp Med"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R29","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/hep.510290311","article-title":"Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection.","volume":"29","author":"Villano","year":"1999","journal-title":"Hepatology"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R30","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1086\/522608","article-title":"Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance.","volume":"196","author":"Wang","year":"2007","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R31","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1086\/595979","article-title":"Late appearance of hepatitis C virus RNA after needlestick injury: necessity for a more intensive follow-up.","volume":"30","author":"Gruener","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R32","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jhep.2008.11.023","article-title":"Acute infection with a single hepatitis C virus strain in dialysis patients: analysis of adaptive immune response and viral variability.","volume":"50","author":"Weseslindtner","year":"2009","journal-title":"J Hepatol"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R33","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1097\/MCG.0000000000000076","article-title":"Distinct features in natural history and outcomes of acute hepatitis C.","volume":"49","author":"Bunchorntavakul","year":"2015","journal-title":"J Clin Gastroenterol"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R34","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1093\/infdis\/jiv220","article-title":"Hepatitis C virus reinfection and spontaneous clearance of reinfection\u2014the InC3 Study.","volume":"212","author":"Sacks-Davis","year":"2015","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R35","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1053\/jhep.2002.36129","article-title":"Outcome of an outbreak of acute hepatitis C among healthy volunteers participating in pharmacokinetics studies.","volume":"36","author":"Larghi","year":"2002","journal-title":"Hepatology"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R36","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/QAD.0b013e32831940a3","article-title":"Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV.","volume":"23","author":"Thomson","year":"2009","journal-title":"AIDS"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R37","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1093\/cid\/ciu695","article-title":"Hepatitis C virus (HCV) antibody dynamics following acute HCV infection and reinfection among HIV-infected men who have sex with men.","volume":"59","author":"Vanhommerig","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R38","doi-asserted-by":"publisher","first-page":"61","DOI":"10.15585\/mmwr.mm6803a2","article-title":"Characteristics of deceased solid organ donors and screening results for hepatitis B, C, and human immunodeficiency viruses\u2014United States, 2010\u20132017.","volume":"68","author":"Abara","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R39","unstructured":"University of California at San Francisco\/Clinician Consultation Center. PEP quick guide for occupational exposures: exposures to HCV. San Francisco, CA: University of California; 2019. http:\/\/nccc.ucsf.edu\/clinical-resources\/pep-resources\/pep-quick-guide-for-occupational-exposures\/#_edn1"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R40","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1093\/cid\/ciw656","article-title":"Hepatitis C virus postexposure prophylaxis in the healthcare worker: why direct-acting antivirals don\u2019t change a thing.","volume":"64","author":"Naggie","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R41","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/QCO.0000000000000281","article-title":"Postexposure prophylaxis after hepatitis C occupational exposure in the interferon-free era.","volume":"29","author":"Hughes","year":"2016","journal-title":"Curr Opin Infect Dis"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R42","unstructured":"National Library of Medicine. HCV post-exposure prophylaxis for health care workers [Internet]. Bethesda, MD: National Library of Medicine [undated]. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03313414?id=NCT03313414&rank=1&load=cart"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R43","first-page":"362","article-title":"Testing for HCV infection: an update of guidance for clinicians and laboratorians.","volume":"62","author":"CDC","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcv.2017.01.007","article-title":"Prevalence of false-positive hepatitis C antibody results, National Health and Nutrition Examination Study (NHANES) 2007\u20132012.","volume":"89","author":"Moorman","year":"2017","journal-title":"J Clin Virol"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R45","article-title":"CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management.","volume":"62","author":"Schillie","year":"2013","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr6906a1-202007231105-R46","unstructured":"CDC. Infection control in healthcare personnel: infrastructure and routine practices for occupational infection prevention and control services (2019). Atlanta, GA: US Department of Health and Human Services, CDC; 2019. https:\/\/www.cdc.gov\/infectioncontrol\/guidelines\/healthcare-personnel\/exec-summary.html?deliveryName=USCDC_425-DHQP-DM11130"}],"container-title":["MMWR. Recommendations and Reports"],"original-title":[],"deposited":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T15:06:55Z","timestamp":1595516815000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/69\/rr\/rr6906a1.htm?s_cid=rr6906a1_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,24]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,7,24]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.rr6906a1","relation":{},"ISSN":["1057-5987","1545-8601"],"issn-type":[{"value":"1057-5987","type":"print"},{"value":"1545-8601","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,7,24]]},"published":{"date-parts":[[2020,7,24]]}}}